| Company Name: | Kensey Nash Corporation | | Ticker Symbol: | KNSY | | | WWW Address: | www.kenseynash.com | | CEO: | Joseph W. Kaufmann | | No. of Employees: | 302 | | Common Issue Type: | CS | | Business Description: | The Company is engaged in developing, manufacturing and processing resorbable biomaterials products, incorporating its proprietary collagen and synthetic polymer technology.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 24.16 |  0.02 | 23.57 | 25.07 | 24.14 | 24.69 | 24.10 | 51377 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 268.2 | 11.1 | 0.95 | 1.69 | 0.00 | 14.2 | 0.0 | 29.73 - 15.11 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 24.16 | $ | | PE Ratio - LTM | 14.2 | |
| Market Capitalisation | 268.0 | mil |
| Latest Shares Outstanding | 11.1 | mil |
| Earnings pS (EPS) | 1.69 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 271,791 | $ |
| Effective Tax Rate | 32.6 | % |
| Float | 9.7 | mil |
| Float as % of Shares Outstanding | 87.1 | % |
| Foreign Sales | 1 | mil |
| Domestic Sales | 82 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.20 | % |
| Research & Devlopment (R&D) as % of Revenue | 22.00 | % |
| Gross Profit Margin | 78.7 | % |
| EBITDA Margin | 45.5 | % |
| Pre-Tax Profit Margin | 35.9 | % |
| Assets Turnover | 0.5 | % |
| Return on Assets (ROA) | 11.1 | % |
| Return on Equity (ROE) | 15.4 | % |
| Return on Capital Invested (ROCI) | 12.4 | % |
| Current Ratio | 9.5 | |
| Leverage Ratio (Assets/Equity) | 1.4 | |
| Interest Cover | 14.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.25 | |
| LT Debt/Total Capital | 19.0 | % |
| Working Capital pS | 9.06 | $ |
| Cash pS | 5.12 | $ |
| Book-Value pS | 11.56 | $ |
| Tangible Book-Value pS | 10.91 | $ |
| Cash Flow pS | 2.37 | $ |
| Free Cash Flow pS | 2.66 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.09 | |
| Price/Tangible Book Ratio | 2.21 | |
| Price/Cash Flow | 10.2 | |
| Price/Free Cash Flow | 9.1 | |
| P/E as % of Industry Group | 48.0 | % |
| P/E as % of Sector Segment | 28.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 3.7 | 102 | 521 | 1,345 |
| 4 Weeks | 25.00 | 22.69 | 23.91 | 1.0 | 94 | 573 | 10,308 |
| 13 Weeks | 29.43 | 22.69 | 26.52 | -8.9 | 84 | 662 | 41,034 |
| 26 Weeks | 29.73 | 22.69 | 25.04 | -3.5 | 80 | 591 | 74,466 |
| 52 Weeks | 29.73 | 15.11 | 18.48 | 30.7 | 105 | 723 | 180,810 |
| YTD | 29.73 | 15.11 | - | 24.5 | 101 | 684 | 155,933 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 23.70 | 23.72 | 26.00 | 25.99 | 24.30 | 0.95 | 0.82 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 16.73 | 88.3 | 10.32 |
| Income | 3.71 | 0.8 | 62.16 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 2.41 | NA | -2.77 |
| Normalized Inc. | 2.92 | NA | 59.08 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -2.0 | -2.0 | 2.9 |
| Earnings % | -7.0 | -7.0 | 319.2 |
| EPS % | 0.0 | 0.0 | 344.7 |
| EPS $ | 0.00 | 0.00 | 1.31 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 55.55 |
| Current Ratio | 10.4 |
| Quick Ratio (Acid Test) | 9.0 |
| Liquidity Ratio (Cash) | 7.88 |
| Receivables Turnover | 6.1 |
| Average Collection Period | 59 |
| Working Capital/Equity | 77.1 |
| Working Capital pS | 8.53 |
| Cash-Flow pS | 2.40 |
| Free Cash-Flow pS | 2.65 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.31 |
| Financial Leverage Ratio (Assets/Equity) | 1.4 |
| Debt Ratio | 27.9 |
| Total Debt/Equity (Gearing Ratio) | 0.27 |
| LT Debt/Equity | 0.25 |
| LT Debt/Capital Invested | 24.4 |
| LT Debt/Total Liabilities | 65.6 |
| Interest Cover | 15.4 |
| Interest/Capital Invested | 1.29 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 1.40 |
| Tobin's Q Ratio | 1.57 |
| Current P/E Ratio - LTM | 14.20 |
| Enterprise Value (EV)/EBITDA | 6.34 |
| Enterprise Value (EV)/Free Cash Flow | 9.15 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.21 |
| Price/Book Ratio - LTM | 2.09 |
| Price/Cash Flow Ratio | 10.2 |
| Price/Free Cash Flow Ratio - LTM | 9.1 |
| Price/Sales Ratio | 3.28 |
| P/E Ratio (1 month ago) - LTM | 14.2 |
| P/E Ratio (26 weeks ago) - LTM | 20.9 |
| P/E Ratio (52 weeks ago) - LTM | 22.3 |
| 5-Y High P/E Ratio | 116.2 |
| 5-Y Low P/E Ratio | 8.9 |
| 5-Y Average P/E Ratio | 63.8 |
| Current P/E Ratio as % of 5-Y Average P/E | 22 |
| P/E as % of Industry Group | 48.0 |
| P/E as % of Sector Segment | 28.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.2 |
| PER SHARE FIGURES |
| LT Debt pS | 2.82 |
| Current Liabilities pS | 0.91 |
| Tangible Book Value pS - LTM | 10.91 |
| Book Value pS - LTM | 11.56 |
| Capital Invested pS | 13.94 |
| Cash pS - LTM | 5.12 |
| Cash Flow pS - LTM | 2.37 |
| Free Cash Flow pS - LTM | 2.66 |
| Earnings pS (EPS) | 1.69 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 36.00 |
| Free Cash Flow Margin 5YEAR AVG | 1.89 |
| Net Profit Margin | 24.5 |
| Net Profit Margin - 5YEAR AVRG. | 13.6 |
| Equity Productivity | 0.67 |
| Return on Equity (ROE) | 16.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 7.8 |
| Capital Invested Productivity | 0.53 |
| Return on Capital Invested (ROCI) | 13.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 6.9 |
| Assets Productivity | 0.50 |
| Return on Assets (ROA) | 11.7 |
| Return on Assets (ROA) - 5YEAR AVRG. | 6.3 |
| Gross Profit Margin | 78.7 |
| Gross Profit Margin - 5YEAR AVRG. | 76.5 |
| EBITDA Margin - LTM | 45.5 |
| EBIT Margin - LTM | 38.5 |
| Pre-Tax Profit Margin | 36.3 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 19.1 |
| Effective Tax Rate | 32.6 |
| Effective Tax Rate - 5YEAR AVRG. | 25.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 255 |
| Revenue per Employee | 271,791 |
| Net Income per Employee | 66,487 |
| Average Collection Period | 50 |
| Receivables Turnover | 6.1 |
| Day's Inventory Turnover Ratio | 205 |
| Inventory Turnover | 1.8 |
| Inventory/Sales | 12.9 |
| Accounts Payble/Sales | 2.56 |
| Assets/Revenue | 2.00 |
| Net Working Capital Turnover | 0.86 |
| Fixed Assets Turnover | 1.25 |
| Total Assets Turnover | 0.5 |
| Revenue per $ Cash | 1.66 |
| Revenue per $ Plant | 1.42 |
| Revenue per $ Common Equity | 0.67 |
| Revenue per $ Capital Invested | 0.53 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 11.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 26.1 |
| Research & Devlopment (R&D) as % of Revenue | 22.1 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 22.1 |
|
|  
|
| |
 |  |